Noradrenergic A7 neurons and Upper Airway Motor Control

去甲肾上腺素能 A7 神经元和上呼吸道运动控制

• 批准号: 8526015
• 负责人: Victor Borisovich Fenik
• 金额: $ 29.27万
• 依托单位: BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-06-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8526015
• 关键词: Adrenergic Agents; Adrenergic Receptor; Adult; Affect; Agonist; Animal Model; Behavior; Carbachol; Clinical; Clonidine; Congestive Heart Failure; Consensus; Coronary Arteriosclerosis; Data; Diabetes Mellitus; Disease; Excessive Daytime Sleepiness; Foundations; Glycine; Head; Health; Hypertension; Knowledge; Mental Depression; Microinjections; Motor Neurons; Muscle; Muscle Tonus; Neurons; Neurosciences; Neurotransmitters; Obstruction; Obstructive Sleep Apnea; Operative Surgical Procedures; Oral; Pathology; Patients; Pattern; Pharmacological Treatment; Play; Pontine structure; Population; Proteins; Quality of life; REM Sleep; Rattus; Relative (related person); Research; Role; Sleep; Sleep Wake Cycle; Spinal; Stroke; Testing; Tongue; Wakefulness; adrenergic; airway obstruction; extracellular; gamma-Aminobutyric Acid; hypoglossal nucleus; locus ceruleus structure; motor control; nerve supply; neurobiotin; neurochemistry; neurotransmission; non rapid eye movement; noradrenergic; novel; postsynaptic; public health relevance; receptor; research study

DESCRIPTION (provided by applicant): Obstructive Sleep Apnea (OSA) is a growing health problem which affects almost 5% of the adult population. Due to airway obstruction and repetitive waking during sleep, OSA patients have excessive daytime sleepiness and a diminished quality of life. OSA is associated with hypertension, diabetes, coronary artery disease, strokes and congestive heart failure. The treatment options for OSA are limited to surgery and the use of oral appliances; no effective pharmacological therapy is available. Hypoglossal motoneurons play a critical role in pathology of the OSA because they innervate the muscles of the tongue that are important for maintaining airway patency. A decrease in their activity during sleep and especially rapid eye movement (REM) sleep is the main cause of airway obstruction in OSA. Therefore, complete understanding of the neuronal network that controls activity of hypoglossal motoneurons during sleep and wakefulness may help to develop pharmacological strategies to treat OSA. In the proposed project, we will study the role of noradrenergic A7 neurons in the neuronal network that controls activity of hypoglossal motoneurons during the natural sleep-wake cycle using a novel animal model. We will obtain data regarding behavior of A7 neurons during states of sleep and wakefulness, their downstream projections and their contribution to the mechanisms of the depression of hypoglossal motoneurons excitability during non-REM and REM sleep. Obtained information will advance our understanding of the neuronal network and neurochemical mechanisms that control state-dependent activity of hypoglossal motoneurons and provide a foundation for developing effective pharmacological treatments for OSA

描述（由申请人提供）：阻塞性睡眠呼吸暂停（OSA）是一个日益严重的健康问题，影响了近5%的成年人。由于气道阻塞和睡眠中反复醒来，OSA患者白天嗜睡过度，生活质量下降。阻塞性睡眠呼吸暂停与高血压、糖尿病、冠状动脉疾病、中风和充血性心力衰竭有关。阻塞性睡眠呼吸暂停的治疗选择仅限于手术和使用口腔矫治器；目前尚无有效的药物治疗方法。舌下运动神经元在阻塞性睡眠呼吸暂停的病理中起着关键作用，因为它们支配着维持气道通畅的重要舌头肌肉。睡眠期间，尤其是快速眼动（REM）睡眠期间，它们的活动减少是阻塞性睡眠呼吸暂停（OSA）患者气道阻塞的主要原因。因此，全面了解睡眠和清醒时控制舌下运动神经元活动的神经网络可能有助于制定治疗OSA的药物策略。在这个项目中，我们将使用一种新的动物模型来研究在自然睡眠-觉醒周期中，去肾上腺素能A7神经元在控制舌下运动神经元活动的神经网络中的作用。我们将获得A7神经元在睡眠和清醒状态下的行为、它们的下游投射以及它们对非快速眼动和快速眼动睡眠期间舌下运动神经元兴奋性抑制的机制的贡献。获得的信息将促进我们对控制舌下运动神经元状态依赖性活动的神经网络和神经化学机制的理解，并为开发有效的OSA药物治疗提供基础